2019/11/02 Gut Pathobionts Underlie IntestinalBarrier Dysfunction snf Liver Th17 Immune Response in Primary Sclerosing Cholangitis
2019/11/02 “Tailoring Immunity in Patients with HBV or HCV Infection – Aiming at the Virus Elimination by 2030”
![The Asian Pacific Association for the Study of the Liver [APASL]](https://www.apasl.info/wp-apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}